3-(1-Benzyl-1H-tetrazol-5-yl)-1-(phenyl)-beta-carboline

ID: ALA4475631

PubChem CID: 155538043

Max Phase: Preclinical

Molecular Formula: C25H18N6

Molecular Weight: 402.46

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  c1ccc(Cn2nnnc2-c2cc3c([nH]c4ccccc43)c(-c3ccccc3)n2)cc1

Standard InChI:  InChI=1S/C25H18N6/c1-3-9-17(10-4-1)16-31-25(28-29-30-31)22-15-20-19-13-7-8-14-21(19)26-24(20)23(27-22)18-11-5-2-6-12-18/h1-15,26H,16H2

Standard InChI Key:  AFDXKGQYLTVDEP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 36  0  0  0  0  0  0  0  0999 V2000
   26.1418  -13.1122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.3246  -13.1122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0748  -12.3365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2798  -12.1664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7337  -12.7710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9882  -13.5484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7827  -13.7149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7332  -11.8534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3948  -12.3357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1411  -12.0038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2271  -11.1899    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.5608  -10.7090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8171  -11.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6397   -9.8943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3459   -9.4832    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.1732   -8.6845    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.3602   -8.6019    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.0305   -9.3496    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.8000  -12.4805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7127  -13.2941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3728  -13.7746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1205  -13.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2041  -12.6255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5431  -12.1486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2318   -9.5224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6829   -8.9170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9368   -8.1414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3886   -7.5364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5890   -7.7089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3404   -8.4918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8903   -9.0935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  9  1  0
  8  3  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 14  1  0
 12 14  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 10 19  1  0
 18 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4475631

    ---

Associated Targets(Human)

U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI/ADR-RES (33767 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 402.46Molecular Weight (Monoisotopic): 402.1593AlogP: 5.08#Rotatable Bonds: 4
Polar Surface Area: 72.28Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.46CX Basic pKa: CX LogP: 5.42CX LogD: 5.42
Aromatic Rings: 6Heavy Atoms: 31QED Weighted: 0.45Np Likeness Score: -1.03

References

1. Panice MR, Lopes SMM, Figueiredo MC, Goes Ruiz ALT, Foglio MA, Nazari Formagio AS, Sarragiotto MH, Pinho E Melo TMVD..  (2019)  New 3-tetrazolyl-β-carbolines and β-carboline-3-carboxylates with anti-cancer activity.,  179  [PMID:31247374] [10.1016/j.ejmech.2019.05.085]

Source